Myotonic Disorders Overview
Myotonic disorders are a heterogeneous group of genetically determined neuromuscular diseases unified by the presence of myotonia—the failure of muscle relaxation after activation—and are classified into two main categories: dystrophic myotonias (Myotonic Dystrophy Types 1 and 2) and non-dystrophic myotonias (channelopathies affecting chloride or sodium channels). 1, 2, 3
Dystrophic Myotonias
Myotonic Dystrophy Type 1 (DM1)
- Caused by expansion of an unstable CTG trinucleotide repeat in the 3′ untranslated region of the DMPK gene on chromosome 19, with normal alleles having 5-34 repeats, variable alleles 35-49 repeats, and pathogenic alleles ≥50 repeats 4, 1
- Inheritance is autosomal dominant with nearly complete penetrance but variable expressivity, showing anticipation (increasing severity in successive generations) with earlier age of onset 4, 1
- Multisystem disease characterized by distal muscle weakness and wasting, myotonia, cataracts, cardiac conduction defects, endocrine abnormalities (diabetes, hypogonadism), and neurobehavioral changes 2, 5
- Cardiac manifestations occur in approximately 80% of patients and are a major cause of mortality, including conduction defects and tachyarrhythmias 1, 6
- Congenital form (>1000 CTG repeats) presents with severe hypotonia, respiratory distress, developmental delay, and high early mortality 4
Myotonic Dystrophy Type 2 (DM2/PROMM)
- Caused by expansion of a CCTG repeat in intron 1 of the CNBP gene on chromosome 3, with more variable clinical manifestations and later age of onset (20-70 years) than DM1 1, 5
- Characterized by proximal muscle weakness (rather than distal), myotonia, muscle pain (myalgia), and multisystem involvement, but typically milder than DM1 2, 7
- Cardiac problems are less frequent (10-20%) and typically less severe than in DM1 1
- No clear anticipation pattern is observed, distinguishing it from DM1 7
Non-Dystrophic Myotonias (Channelopathies)
Chloride Channel Disorders
- Myotonia Congenita (Thomsen's disease - autosomal dominant; Becker type - autosomal recessive) caused by mutations in the CLCN1 gene encoding the muscle chloride channel 2, 8
- Clinical picture dominated by myotonia without progressive muscle weakness or systemic involvement, with possible muscle hypertrophy and mild episodic weakness 2, 3
- Can range from asymptomatic electrical myotonia to significant functional impairment 3
Sodium Channel Disorders
- Three distinct disorders caused by mutations in the SCN4A gene encoding the muscle sodium channel: paramyotonia congenita, hyperkalemic periodic paralysis (adynamia episodica hereditaria), and myotonia fluctuans 2, 8
- Paramyotonia congenita characterized by myotonia that worsens with cold exposure and repeated muscle activity (paradoxical myotonia), often with episodic weakness 2, 8
- Dominated by myotonia with minor muscular complaints such as mild episodic weakness and muscle hypertrophy, without progressive weakness or systemic features 2
Clinical Context for Isolated Foot Cramps
For a patient presenting with isolated sharp foot cramps without other neurologic or systemic signs, myotonic disorders are unlikely to be the primary diagnosis, as true myotonic disorders present with characteristic delayed muscle relaxation (myotonia) rather than simple cramping 2, 3. However, if considering myotonic disorders in the differential:
- Mild forms of myotonia congenita or sodium channelopathies could theoretically present with predominantly distal symptoms, though myotonia (stiffness with delayed relaxation) would be the hallmark, not isolated cramping 2, 3
- DM1 with 50-100 CTG repeats (mild disease form) can present with subtle symptoms including mild myotonia, but would typically show additional features like cataracts or family history 4
- Electromyography showing myotonic discharges (dive-bomber pattern) is essential for detecting myotonia even when clinical myotonia is absent or subtle 9
Critical Diagnostic Pitfalls
- Distinguish true myotonia (delayed muscle relaxation after contraction) from muscle cramping, spasms, or stiffness, as these are fundamentally different phenomena 3
- In dystrophic myotonias, cardiac screening is mandatory even when patients are asymptomatic, as conduction abnormalities and arrhythmias are leading causes of sudden death, with annual ECG and echocardiography recommended 6
- For DM1 patients requiring permanent pacing, an ICD should be considered over a pacemaker alone to minimize sudden cardiac arrest risk from ventricular tachycardia 4, 6
- Genetic testing with CTG repeat analysis is the definitive diagnostic test for DM1, while clinical diagnosis and genetic testing for specific channel mutations confirm non-dystrophic myotonias 4, 2